OmniStar Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.39M | Sell |
24,319
-9,533
| -28% | -$1.33M | 1.76% | 12 |
|
|
2025
Q4 | $4.16M | Buy |
33,852
+2,779
| +9% | +$338K | 2.44% | 7 |
|
|
2025
Q3 | $3.45M | Buy |
31,073
+16,117
| +108% | +$1.83M | 2.09% | 7 |
|
|
2025
Q2 | $1.66M | Buy |
14,956
+2,697
| +22% | +$287K | 1.24% | 23 |
|
|
2025
Q1 | $1.38M | Sell |
12,259
-5,525
| -31% | -$570K | 1.09% | 27 |
|
|
2024
Q4 | $1.64M | Buy |
17,784
+7,877
| +80% | +$709K | 1.32% | 17 |
|
|
2024
Q3 | $833K | Sell |
9,907
-149
| -1% | -$11.4K | 0.62% | 49 |
|
|
2024
Q2 | $690K | Buy |
10,056
+873
| +10% | +$58.3K | 0.62% | 54 |
|
|
2024
Q1 | $673K | Sell |
9,183
-1,023
| -10% | -$78.7K | 0.62% | 65 |
|
|
2023
Q4 | $827K | Sell |
10,206
-6,826
| -40% | -$531K | 1.04% | 29 |
|
|
2023
Q3 | $1.28M | Sell |
17,032
-8
| -0% | -$615 | 1.52% | 15 |
|
|
2023
Q2 | $1.31M | Sell |
17,040
-93
| -0.5% | -$7.42K | 1.54% | 14 |
|
|
2023
Q1 | $1.42M | Buy |
17,133
+1,816
| +12% | +$150K | 1.8% | 11 |
|
|
2022
Q4 | $1.31M | Sell |
15,317
-8,259
| -35% | -$654K | 1.49% | 16 |
|
|
2022
Q3 | $1.45M | Buy |
23,576
+3,192
| +16% | +$201K | 1.73% | 11 |
|
|
2022
Q2 | $1.26M | Buy |
20,384
+274
| +1% | +$17K | 1.4% | 20 |
|
|
2022
Q1 | $1.2M | Buy |
20,110
+6,698
| +50% | +$428K | 1.19% | 27 |
|
|
2021
Q4 | $973K | Buy |
13,412
+1,663
| +14% | +$115K | 1% | 31 |
|
|
2021
Q3 | $820K | Buy |
+11,749
| New | +$825K | 0.97% | 37 |
|
|
2021
Q2 | – | Sell |
-11,554
| Closed | -$771K | – | 126 |
|
|
2021
Q1 | $747K | Sell |
11,554
-5,726
| -33% | -$369K | 0.95% | 40 |
|
|
2020
Q4 | $1.01M | Sell |
17,280
-1,198
| -6% | -$72.3K | 0.71% | 51 |
|
|
2020
Q3 | $1.17M | Buy |
18,478
+8,849
| +92% | +$614K | 0.88% | 42 |
|
|
2020
Q2 | $741K | Buy |
9,629
+1,642
| +21% | +$126K | 0.61% | 62 |
|
|
2020
Q1 | $597K | Sell |
7,987
-269
| -3% | -$18.6K | 0.59% | 56 |
|
|
2019
Q4 | $537K | Sell |
8,256
-820
| -9% | -$53.4K | 0.45% | 74 |
|
|
2019
Q3 | $575K | Buy |
9,076
+453
| +5% | +$29.6K | 0.5% | 68 |
|
|
2019
Q2 | $583K | Buy |
8,623
+1,316
| +18% | +$86.6K | 0.52% | 67 |
|
|
2019
Q1 | $475K | Buy |
7,307
+1,252
| +21% | +$83.2K | 0.42% | 79 |
|
|
2018
Q4 | $379K | Sell |
6,055
-1,095
| -15% | -$76.5K | 0.39% | 75 |
|
|
2018
Q3 | $552K | Buy |
7,150
+1,389
| +24% | +$105K | 0.42% | 72 |
|
|
2018
Q2 | $408K | Sell |
5,761
-1
| -0% | -$71 | 0.39% | 72 |
|
|
2018
Q1 | $434K | Sell |
5,762
-659
| -10% | -$52.4K | 0.41% | 67 |
|
|
2017
Q4 | $460K | Buy |
+6,421
| New | +$488K | 0.42% | 68 |
|
Other funds holding GILD
VCM
VPM
OmniStar Financial Group's GILD Position: Q1 2026 in Review
OmniStar Financial Group reduced its Gilead Sciences (GILD) stake by 28% in Q1 2026, selling an estimated $1.33M and leaving 24,319 shares worth $3.39M. The position accounts for 1.76% of the portfolio, ranked #12.
OmniStar Financial Group first reported a position in GILD in Q4 2017 and has held it in 33 quarters since. The position peaked at $4.16M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- OmniStar Financial Group held 24,319 shares of Gilead Sciences worth $3.39M as of Q1 2026.
- OmniStar Financial Group sold 9,533 Gilead Sciences shares in Q1 2026, an estimated $1.33M.
- Gilead Sciences made up 1.76% of OmniStar Financial Group's portfolio in Q1 2026, its #12 holding.
- OmniStar Financial Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 33 quarters since.
- OmniStar Financial Group's Gilead Sciences position peaked at $4.16M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on OmniStar Financial Group's 13F filing for Q1 2026, filed 15 May 2026.